We developed different ACC xenograft mouse models to study the RGZ effects in vivo on tumor growth and the CXCL12/CXCR4 axis in a therapeutic and a prevention setting, comparing them with MTT. Here, CXCR4 is linked to adrenal cortex carcinoma.